JP2004529133A5 - - Google Patents

Download PDF

Info

Publication number
JP2004529133A5
JP2004529133A5 JP2002576901A JP2002576901A JP2004529133A5 JP 2004529133 A5 JP2004529133 A5 JP 2004529133A5 JP 2002576901 A JP2002576901 A JP 2002576901A JP 2002576901 A JP2002576901 A JP 2002576901A JP 2004529133 A5 JP2004529133 A5 JP 2004529133A5
Authority
JP
Japan
Prior art keywords
channel
type
inactivating
slowly
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002576901A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004529133A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/009575 external-priority patent/WO2002078633A2/en
Publication of JP2004529133A publication Critical patent/JP2004529133A/ja
Publication of JP2004529133A5 publication Critical patent/JP2004529133A5/ja
Pending legal-status Critical Current

Links

JP2002576901A 2001-03-30 2002-03-29 前立腺肥大症に伴う膀胱刺激症状治療剤 Pending JP2004529133A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27969901P 2001-03-30 2001-03-30
PCT/US2002/009575 WO2002078633A2 (en) 2001-03-30 2002-03-29 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia

Publications (2)

Publication Number Publication Date
JP2004529133A JP2004529133A (ja) 2004-09-24
JP2004529133A5 true JP2004529133A5 (enExample) 2005-12-22

Family

ID=23070055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002576901A Pending JP2004529133A (ja) 2001-03-30 2002-03-29 前立腺肥大症に伴う膀胱刺激症状治療剤

Country Status (5)

Country Link
US (2) US7122173B2 (enExample)
EP (1) EP1372639A4 (enExample)
JP (1) JP2004529133A (enExample)
CA (1) CA2442452A1 (enExample)
WO (1) WO2002078633A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132803A1 (en) * 2002-03-29 2004-07-08 Tsuyoshi Yamagata Agent for the treatment of overactive bladder
WO2004087131A1 (ja) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. 鎮咳剤
TW200501938A (en) * 2003-06-27 2005-01-16 Kyowa Hakko Kogyo Kk A medicament for therapeutic treating overactive urinary bladder accompany with cerebrovascular disorder
EP1649855A1 (en) * 2003-07-16 2006-04-26 Kyowa Hakko Kogyo Co., Ltd. Medicinal composition
TW200827367A (en) * 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome
WO2009131201A1 (ja) * 2008-04-25 2009-10-29 協和発酵キリン株式会社 間欠性跛行症治療剤
US12274680B2 (en) 2022-09-13 2025-04-15 II George William Creasy Treatment of benign prostatic hypertrophy with capsinoids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310095D0 (en) * 1993-05-17 1993-06-30 Zeneca Ltd Therapeutic compounds
PT979821E (pt) * 1997-04-15 2007-01-31 Kyowa Hakko Kogyo Kk Compostos triciclicos
US6610386B2 (en) * 1998-12-31 2003-08-26 Eastman Kodak Company Transferable support for applying data to an object
US20040132803A1 (en) 2002-03-29 2004-07-08 Tsuyoshi Yamagata Agent for the treatment of overactive bladder

Similar Documents

Publication Publication Date Title
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
EA200100678A1 (ru) N-уреидоалкил-пиперидины в качестве модуляторов активности рецепторов хемокинов
NL300385I1 (nl) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases.
RU2003135482A (ru) Геропротектор на основе гидрированных пиридо(4,3-b) индолов (варианты), фармакологическое средство на его основе и способ его применения
EP2210606A3 (en) Compositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases
MXPA02012712A (es) N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas.
EP1369418A4 (en) Quinazoline derivatives
NO20041059L (no) Kombinasjon av utvalgte opioder med muskarinantagonister for behandling av urininkontinens
WO2001028987A8 (en) Benzylcycloalkyl amines as modulators of chemokine receptor activity
DE60302157D1 (de) Opioidrezeptorantagonisten
CA2386793A1 (en) New selective retinoid agonists
BR0013793A (pt) Medicamentos profiláticos e terapêuticos para doenças oftálmicas
JP2004529133A5 (enExample)
WO2001098270A3 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
WO2001098269A3 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
WO2002078633A3 (en) Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia
WO2006064228A3 (en) Thiazolopyramidine compounds for the modulation of chemokine receptor activity
JP2005506296A5 (enExample)
CA2370501A1 (en) Pharmaceutical composition for the therapy of lower urinary tract symptoms
WO2005048932A3 (en) N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
EP1679296A4 (en) DERIVE ETHERE
HRPK20040328B3 (en) Pharmaceutical composition comprising gamma-butyrobetaine
DE60039782D1 (de) Amidinophenylbrenztraubensäure-derivat
HUP0301334A2 (hu) Szubsztituált akriloil-disztamicin-származékokat és taxánokat és/vagy antimetabolitokat tartalmazó kombinált tumorellenes kompozíciók